Quantitation of oxcarbazepine and its metabolites in human plasma by micellar electrokinetic chromatography

Biomedical Chromatography

Volumn 17, Issue 4, 2003, Pages 231-238

  Pucci, Vincenzo ^a   Kenndler, Ernst ^b   Raggi, Maria Augusta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

10,11 dihydro 10 hydroxy carbamazepine; 10,11 dihydro 10 oxo 5H dibenz b,f azepin 5 carboxamide; Antiepileptic; Carbamazepine; Solid phase extraction; Trans 10, 11 dihydro 10,11 dihydroxycarbamazepine

Indexed keywords

BIOMOLECULES; CHROMATOGRAPHIC ANALYSIS; ELECTRODYNAMICS; EXTRACTION; FUSED SILICA; GAUSSIAN DISTRIBUTION; PATIENT TREATMENT; PHASE SEPARATION;

10,11-DIHYDRO-10-HYDROXY-CARBAMAZEPINE; 10,11-DIHYDRO-10-OXO-5H-DIBENZ-[B,F] AZEPIN-5-CARBOXAMIDE; ANALYTES; ANTIEPILEPTICS; CARBAMAZEPINE; CARBOXAMIDES; OXCARBAZEPINE; SOLID-PHASE EXTRACTION; TRANS-10, 11-DIHYDRO-10,11-DIHYDROXYCARBAMAZEPINE;

METABOLITES;

10,11 DIHYDRO 10,11 DIHYDROXYCARBAMAZEPINE; ANTICONVULSIVE AGENT; BUFFER; DRUG METABOLITE; LICARBAZEPINE; MELATONIN; METHANOL; OXCARBAZEPINE; PHOSPHATE; SILICON DIOXIDE;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; CAPILLARY CHROMATOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; ELECTRIC CURRENT; ELECTRIC POTENTIAL; EPILEPSY; HUMAN; LINEAR SYSTEM; MATERIAL COATING; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; SPECTROPHOTOMETRY;

EID: 0038386872     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.217     Document Type: Article

References (27)

1. Barcs G, Walker EB, Elger CE, Scaramelli A, Stefan H, Sturm Y, Moore A, Flesch G, Kramer L and D'Souza J. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsy 2000; 41: 1597.
2. Beyodun A, Sachdeo RC, Rosenfeld WE, Krauss GL, Sessler N, Mesenbrink P, Kramer L and D'Souza J. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 2000; 54: 2245.
3. Bialer M. Comparative pharmacokinetics of the newer antiepileptic drugs. Clinical Pharmacokinetics 1993; 24: 441.
4. Duncan JS. The promise of new antiepileptic drugs. British Journal of Clinical Pharmacology 2002; 53: 123.
5. Grant SM and Faulds D. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 1992; 43: 873.
6. Ivanova M, Marziali E, Raggi MA and Kenndler E. Microemulsion micellar electrokinetic chromatography for the separation of carbamazepine, oxcarbazepine and their metabolites. Journal of Separation Science 2002; 25: 863.
7. Kalis MM and Huff NA. Oxcarbazepine, an antiepileptic agent. Clinical Therapeutics 2001; 23: 680.
8. Kalviamen R, Keranen T and Riekkinen PJ Sr. Place of newer antiepileptic drugs in the treatment of epilepsy. Drugs 1993; 46: 1009.
9. Kumps A. Simultaneous HPLC determination of oxcarbazepine, carbamazepine and their metabolites in serum. Journal of Liquid Chromatography 1984; 7: 1235.
10. Larkin JG, McKee PJW, Forrest G, Beastall GH, Park BK, Lowrie JI, Lloyd P and Brodie MJ. Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects. British Journal of Clinical Pharmacology 1991; 31: 65.
11. Levert H, Odou P and Robert H. LC dtermination of oxcarbazepine and its active metabolites in human serum. Journal of Pharmaceutical and Biomedical Analysis 2002a; 28: 517.
12. Levert H, Odou P and Robert H. Simultaneous determination of four antiepileptic drugs in serum by high-performance liquid chromatography. Biomedical Chromatography 2002b; 16: 19.
13. Mandrioli R, Ghedini N, Albani F, Kenndler E and Raggi MA. Liquid chromatographic determination of oxcarbozepine and its metabolites in plasma of epileptic patients after solid-phase extraction. Journal of Chromatography B 2003; 783: 253.
14. Marziali E, Raggi MA, Komarova N and Kenndler E. Oktakis-6-sulfato-β-cyclodextrin as additive for capillary electrokinetic chromatography of dibenzoazepines:carbamazepine, oxcarbazepine and their metabolites. Electrophoresis 2002; 23: 3020.
15. Menge GP, Dubois JP and Bauer G. Simultaneous determination of carbamazepine, oxcarbazepine and their main metabolites in plasma by liquid chromatography. Journal of Chromatography 1987; 414: 477.
16. Pienimaki P, Fuchs S, Isojarvi J and Vahakangas K. Improved detection of carbamazepine and oxcarbazepine and their metabolites by high-performance liquid chromatography. Journal of Chromatography B 1995; 673: 97.
17. Raggi MA, Pucci V, Maurizio A, Muzikar J and Kenndler E. Separation of carbamazepine and five metabolites and analysis in human plasma by micellar electrokinetic capillary chromatography. Journal of Chromatography B 2002; 770: 217.
18. Sachdeo R, Beydoun A, Schachter S, Vazquez B, Schaul N, Mesenbrink P, Kramer L and D'Souza J. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 2001; 57: 864.
19. Schütz H, Feldmann KF, Faigle JW, Kriemler HP and Winkler T. The metabolism of 14C-oxcarbazepine in man. Xenobiotica 1986; 16: 769.
20. Souppart C, Decherf M, Humbert H and Maurer G. Development of a high throughput 96-well plate sample preparation method for the determination of trileptal (oxcarbazepine) and its metabolites in human plasma. Journal of Chromatography B 2001; 762: 9.
21. Tartara A, Galimberti CA, Manni R, Morini R, Limido G, Gatti G, Bartoli A, Strada G and Perucca E. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy-subjects and in epileptic patients treated with phenobarbitone or valproic acid. British Journal of Clinieal Pharmacology 1993; 36: 366.
22. Theisohn M and Heimann G. Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers. European Journal of Clinical Pharmacology 1982; 22: 545.
23. Tomson T and Johannessen SI. Therapeutic monitoring of the new antiepileptic drugs. European Journal of Clinical Pharmacology 2000; 55: 697.
24. United States Pharmacopeia, 24th edn. United States Pharmacopeial Convention, Rockville, MD, 2000; 304, 2150, 2000.
25. Viola MS, Bercellini MA, Saidon P and Rubio MC. Pharmacokinetic variability of oxcarbazepine in epileptic patients. Medicina 2000; 60: 914.
26. von Unruh GE and Paar WD. Gas chromatographic assay for oxcarbazepine and its main metabolites in plasma. Journal of Chromatography 1985; 345: 67.
27. von Unruh GE and Paar WD. Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol. Biomedical and Environmental Mass Spectrometry 1986; 13: 651.